Department of Internal Medicine
Cardiovascular Medicine Faculty
Medical School:
Washington University
Residency:
University of Pennsylvania
Fellowship:
University of Pennsylvania
Phillip A. Horwitz, M.D.
Clinical Associate Professor
Dr. Horwitz is an Interventional Cardiologist. His clinical interests include high risk coronary artery interventions, peripheral vascular interventions, hemodynamic support during cardiac procedures, atrial septal defect (ASD) and patent foramen ovale (PFO) closure. His research interests include studies of PFO closure for stroke and migraine headaches, new stent technologies and novel pharmacologic management of atherosclerosis and acute coronary syndromes.
Honors, Awards, and Organizations
- Best Doctors in America- 2007-present
- Fellow, American College of Cardiology- 2006-present
- Fellow, Society for Cardiovascular Angiography and Interventions- 2006-present
- American Heart Association- 2003-present
Recent Publications
- Gavrila D, Horwitz PA. Constrictive/Restrictive Cardiac Physiology: Pericarditis or Right Ventricular Infarction? Catheter Cardiovasc Interv. 2007 Nov 15;70(6):868-70
- Walker N, Fasano MB, Hobbs RA, Horwitz PA. Clopidogrel Desensitization Protocol for the Treatment of Thienopyridine Hypersensitivity. Crit Path Cardiolog. 6(1) 26-29, March 2007.
- Walker N, Fasano MB, Horwitz PA. Clopidogrel Desensitization Protocol for the Treatment of Thienopyridine Hypersensitivity: Initial Clinical Experience. Journal of Invasive Cardiolog. 2006 Jul;18(7):341-4
- Horwitz, P.A., Laskey, W.K., Sauer, W.H., Berlin, J.A., Krone, R.J., and Kimmel, S.E.: Bleeding Risks of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Broad-Based Practice: Results from the Society for Cardiac Angiography and Interventions Registry. Am. J. Cardiol., 91(7): 803-806, 2003.
- Kelley, M.P., Klugherz, B.D., Hashemi, S.M., Meneveau, N.F., Johnston, J.M., Matthai, W.H. Jr., Banka, V.S., Herrmann, H.C., Hirshfeld, J.W. Jr., Kimmel, S.E., Kolansky, D.M., Horwitz, P.A., Schiele, F., Bassand, J.P., and Wilensky, R.L.: One-year clinical outcomes of protected and unprotected left main coronary artery stenting. Eur. Heart J. 2003 Sept; 24(17):1554-9.
- Horwitz, P.A., Kimmel S.E.: Bleeding due to Glycoprotein IIb/IIIa Receptor Inhibition During Percutaneous Coronary Intervention: Risk Factors and Management. Cardiovasc Rev Rep 2004; 25:249-255
- Horwitz, P.A., Tsai E.J., Putt M.E., Gilmore J., Lepore J.J., Parmacek M.S., Kao A.C., Desai S., Goldberg L.R., Brozena S.C., Jessup M.L., Epstein J.A., Cappola T.P. Detection of Cardiac Allograft Rejection and Response to Immunsuppressive Therapy With Peripheral Blood Gene Expression. Circulation, 110:3815-21, 2004.
- Herrmann H.C., Silvestry F.E., Glaser R., See V., Kasner S., Bradbury D., Chang G., Hirshfeld J.W., Horwitz P.A., Kelley M.: Percutaneous Patent Foramen Ovale and Atrial Septal Defect Closure in Adults: Results and Device Comparison in 100 Consecutive Implants at a Single Center. Cath and Cardiovasc Interventions 64: 197-203, 2005.
- Konety SH, Horwitz P, Lindower P, Olshansky B. Arrhythmias in tako-tsubo syndrome-Benign or malignant? International Journal of Cardiology,2005 Dec 29.